跳至主要内容
临床试验/NCT00135070
NCT00135070终止4 期

A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia

The Royal Bournemouth Hospital2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2005年7月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
41
试验地点
2
主要终点
Glucose control

研究概览

简要总结

Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.

详细描述

This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar > than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type II diabetes
  • Blood glucose > 17mmols

排除标准

  • Type I diabetes
  • Hyperosmolar non-ketotic coma (HONK)
  • Diabetic ketoacidosis (DKA)
  • Myocardial infarction (MI)

结局指标

主要结局

Glucose control

次要结局

  • Length of stay

研究者

发起方
The Royal Bournemouth Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验